Aliment Pharmacol Ther

1. TOMAS S, Chaparro M, Casanova MJ
   Editorial: Treatment Sequencing in Inflammatory Bowel Disease: Does the Line Matter More Than the Mechanism?
   Aliment Pharmacol Ther. 2026 Sep 17. doi: 10.1111/apt.70983.
   

   >> Share

   
   

   
   Am J Gastroenterol

2. AHMED NS, Boparai R, Fida M, Wang C, et al
   COMPARATIVE REAL-WORLD EFFECTIVENESS OF BIOLOGIC THERAPIES FOR PREVENTING POSTOPERATIVE ENDOSCOPIC RECURRENCE OF CROHN'S DISEASE.
   Am J Gastroenterol. 2026 Sep 18. doi: 10.14309/ajg.0000000000004213.
   

   >> Share

   
   

   
   Am J Surg

3. AVIRAN E, Assaf D, Zaghiyan K, Fleshner P, et al
   Is there a difference in the outcomes of long-term seton placement for complex anal fistula in patients with and without Crohn's disease?
   Am J Surg. 2026;262:117248.
   

   >> Share

   
   

   
   BMC Gastroenterol

4. AMER I, El Batae H, Elshaer YA, Sherief DE, et al
   Leucine-rich alpha-2 glycoprotein as a predictor of primary non-response to anti-TNF-alpha therapy in biologic-naive Egyptian IBD patients.
   BMC Gastroenterol. 2026;26:580.
   

   >> Share

   
   

   
   Clin Gastroenterol Hepatol

5. TAKENAKA K, Tsuchiya J, Kawamoto A, Wakui M, et al
   Baseline Magnetic Resonance Enterography Stratifies Persistence Risk of Crohn's Disease Strictures.
   Clin Gastroenterol Hepatol. 2026 Sep 15:S1542-3565(26)00681.
   

   >> Share

   
   
6. WANG S, Dan L, Ruan X, Wellens J, et al
   Integrated metabolomic and genetic profiling implicate loss of docosahexaenoic acid in the link between ultra-processed foods and Crohn's disease.
   Clin Gastroenterol Hepatol. 2026 Sep 16:S1542-3565(26)00675.
   

   >> Share

   
   
7. SOLIMAN MA, Saraga A, Gade A, Moini SH, et al
   Vedolizumab trough concentrations and clinical and endoscopic outcomes in inflammatory bowel disease: a systematic review and meta-analysis.
   Clin Gastroenterol Hepatol. 2026 Sep 18:S1542-3565(26)00683.
   

   >> Share

   
   

   
   Dig Dis Sci

8. GOLDBECK S, Anderson C, Barr J, Axelrad J, et al
   Impact of Diet and Body Mass Index on the Development of Pouchitis in the First Year After Ileal Pouch-Anal Anastomosis.
   Dig Dis Sci. 2026;71:5473-5479.
   

   >> Share

   
   
9. WANG W, Sun Y, Li J
   Intestinal Fibrosis in IBD: Rethinking the Inflammatory Paradigm and Emerging Therapeutic Opportunities.
   Dig Dis Sci. 2026;71:6009-6019.
   

   >> Share

   
   
10. EASWAR T, Wanchaitanawong W, Ananthakrishnan AN
    Polygenic Risk Scores Show Distinct Genetic Architectures of IBD-Associated Comorbidities.
    Dig Dis Sci. 2026;71:5764-5776.
    

    >> Share

    
    
11. VALLE NP, Roney AR, Noorian S, Greb AC, et al
    The Impact of Perioperative Immunosuppression on Post-surgical Outcomes in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2026 Sep 16. doi: 10.1007/s10620-026-10232.
    

    >> Share

    
    

    
    Gastroenterol Hepatol

12. BELEN-GALIPIENSO O, Baston I, Brunet-Mas E, Calafat M, et al
    Nutritional assessment in inflammatory bowel disease.
    Gastroenterol Hepatol. 2026 Sep 18:502854. doi: 10.1016/j.gastrohep.2026.502854.
    

    >> Share

    
    

    
    Hum Pathol

13. ROSENBERG HJ, Yang D, Bhalla RS, Has P, et al
    Enteric glial cell remodeling at diagnosis is associated with reduced mucosal inflammation at follow-up in pediatric ulcerative colitis.
    Hum Pathol. 2026 Sep 14:106265. doi: 10.1016/j.humpath.2026.106265.
    

    >> Share

    
    

    
    J Crohns Colitis

14. LORAS C, Ruiz-Ramirez P, Gornals JB, Sanchiz V, et al
    Self-expandable metal stents versus endoscopic balloon dilatation for the treatment of strictures in Crohn's disease: a retrospective long-term follow-up of the ProtDilat study, an open label, multicenter, randomized trial.
    J Crohns Colitis. 2026;20:jjag112.
    

    >> Share

    
    
15. MEYER A, Amiot A
    Follow-up duration and tuberculosis do not modify the comparative safety of JAK inhibitors in ulcerative colitis.
    J Crohns Colitis. 2026;20:jjag142.
    

    >> Share

    
    
16. YIN C, He R, Ma H, Fu Y, et al
    Single-cell insights into drug response and resistance in inflammatory bowel disease: cellular hallmarks and precision therapy.
    J Crohns Colitis. 2026;20:jjag136.
    

    >> Share

    
    
17. ROLANDSDOTTER H, Kristjansson K, Everhov AH, Nordenvall C, et al
    Declining rates of surgery in pediatric-onset inflammatory bowel disease: a Swedish nationwide register-based cohort study 2002-2022.
    J Crohns Colitis. 2026;20:jjag127.
    

    >> Share

    
    

    
    Scand J Gastroenterol

18. NAWAZ A, Mody S, Hussain A, Chaar A, et al
    Risk of hepatobiliary and colorectal malignancies in primary sclerosing cholangitis: Crohn's disease with colonic involvement versus ulcerative colitis - a propensity-matched cohort study.
    Scand J Gastroenterol. 2026 Sep 15:1-5. doi: 10.1080/00365521.2026.2731964.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share